docetaxel,rucaparib,abiraterone,enzalutamide
pfizer,astellas,clovis oncology
['rucaparib', 'brca', 'triton-3', 'crpc', 'pcsm', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'docetaxel']
triton-3 results straight from #gu23: rucaparib significantly improved rpfs vs docetaxel or a second-generation arpi in patients with brca1/2-mutated mcrpc. #ascodailynews #pcsm 
Account of the American Society of Clinical Oncology & its affiliate the Association for Clinical Oncology. Assoc tweets labeled #ASCOAdvocacy. RTs ≠ endorse.